~~<i id='CE9075E0C5'><strike id='CE9075E0C5'><tt id='CE9075E0C5'><pre id='CE9075E0C5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：comprehensive 2025-09-30 18:00:15 - browse：59

Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT — Adobe

For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

But don’t take their numbers as gospel, experts warned.

“It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： How doctors and nurses shape Google's AI

focus

explore

hotspot

focus

Wikipedia

focus

Afterphysicallydebilitatingcancertreatment,LaurieBrunnerencounteredanothermedicalhurdle:Shehaddevelo

WSS

Millions may soon lose Medicaid when they don't have to

Medicare to cover more brain scans related to Alzheimer’s drugs

Nick Jonas talks about managing diabetes along with his career

How doctors and nurses shape Google's AI

Bernie Sanders bashes nonprofit hospitals over their tax breaks

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

explore

knowledge

focus

Medicare proposal to cover medical devices draws a mixed reaction

Reanimated hearts work just as well for transplants, study finds

In Memoriam: Notable people who died in 2023

Xenotransplantation trials will require adjusting expectations, experts say

Guidelines to prevent youth baseball injuries need more muscle

Eli Lilly’s Mounjaro succeeds in second weight

Moonlake's readout produced a cash windfall. Risks remain

Humana CEO Bruce Broussard to step down in 2024

Duchenne breakthrough therapy leaves behind pioneering families

Eli Lilly’s Mounjaro succeeds in second weight

explore

Eight reasons why you should get an updated Covid vaccine

Massive project maps cells in human brain in unprecedented detail

Readout LOUD podcast: Merger Mondays, Ozempic panic

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Nick Jonas talks about managing diabetes along with his career

Life sciences deals on track to hit lowest point since 2017

hotspot

focus

Wikipedia

focus